Orexo AB (ORX) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.308x

Based on the latest financial reports, Orexo AB (ORX) has a cash flow conversion efficiency ratio of 0.308x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr151.10 Million ≈ $16.26 Million USD) by net assets (Skr490.60 Million ≈ $52.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Orexo AB - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Orexo AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ORX liabilities breakdown for a breakdown of total debt and financial obligations.

Orexo AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orexo AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dynamic Medical Technologies TWO:4138	0.130x
Sekar Bumi Tbk JK:SKBM	-0.120x
Huikwang TWO:6508	0.004x
Kamdhenu Limited NSE:KAMDHENU	0.039x
Island Pharmaceuticals Ltd AU:ILA	-0.237x
Oswal Agro Mills Limited NSE:OSWALAGRO	0.000x
Gateway Real Estate AG XETRA:GTY	-0.048x
FALCON METALS LTD F:E47	N/A

Annual Cash Flow Conversion Efficiency for Orexo AB (2002–2025)

The table below shows the annual cash flow conversion efficiency of Orexo AB from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see ORX market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr490.60 Million ≈ $52.80 Million	Skr173.00 Million ≈ $18.62 Million	0.353x	+36.62%
2024-12-31	Skr-126.30 Million ≈ $-13.59 Million	Skr-32.60 Million ≈ $-3.51 Million	0.258x	+116.00%
2023-12-31	Skr58.90 Million ≈ $6.34 Million	Skr-95.00 Million ≈ $-10.22 Million	-1.613x	-99.71%
2022-12-31	Skr193.90 Million ≈ $20.87 Million	Skr-156.60 Million ≈ $-16.85 Million	-0.808x	-23.30%
2021-12-31	Skr349.60 Million ≈ $37.62 Million	Skr-229.00 Million ≈ $-24.64 Million	-0.655x	-2277.60%
2020-12-31	Skr558.50 Million ≈ $60.10 Million	Skr16.80 Million ≈ $1.81 Million	0.030x	-92.60%
2019-12-31	Skr706.40 Million ≈ $76.02 Million	Skr287.00 Million ≈ $30.89 Million	0.406x	-20.07%
2018-12-31	Skr476.10 Million ≈ $51.24 Million	Skr242.00 Million ≈ $26.04 Million	0.508x	+14.11%
2017-12-31	Skr329.10 Million ≈ $35.42 Million	Skr146.60 Million ≈ $15.78 Million	0.445x	-11.51%
2016-12-31	Skr310.30 Million ≈ $33.39 Million	Skr156.20 Million ≈ $16.81 Million	0.503x	+231.25%
2015-12-31	Skr266.46 Million ≈ $28.68 Million	Skr-102.19 Million ≈ $-11.00 Million	-0.384x	+64.19%
2014-12-31	Skr455.02 Million ≈ $48.97 Million	Skr-487.30 Million ≈ $-52.44 Million	-1.071x	+34.30%
2013-12-31	Skr161.46 Million ≈ $17.38 Million	Skr-263.20 Million ≈ $-28.32 Million	-1.630x	-1187.18%
2012-12-31	Skr191.19 Million ≈ $20.58 Million	Skr28.67 Million ≈ $3.09 Million	0.150x	+139.79%
2011-12-31	Skr311.10 Million ≈ $33.48 Million	Skr-117.23 Million ≈ $-12.62 Million	-0.377x	-310.64%
2010-12-31	Skr468.24 Million ≈ $50.39 Million	Skr-42.97 Million ≈ $-4.62 Million	-0.092x	+62.41%
2009-12-31	Skr548.66 Million ≈ $59.04 Million	Skr-133.93 Million ≈ $-14.41 Million	-0.244x	-37.04%
2008-12-31	Skr569.78 Million ≈ $61.32 Million	Skr-101.49 Million ≈ $-10.92 Million	-0.178x	+25.50%
2007-12-31	Skr671.25 Million ≈ $72.24 Million	Skr-160.49 Million ≈ $-17.27 Million	-0.239x	-206.76%
2006-12-31	Skr324.35 Million ≈ $34.91 Million	Skr-25.28 Million ≈ $-2.72 Million	-0.078x	+41.80%
2005-12-31	Skr338.91 Million ≈ $36.47 Million	Skr-45.38 Million ≈ $-4.88 Million	-0.134x	+33.29%
2004-12-31	Skr79.44 Million ≈ $8.55 Million	Skr-15.94 Million ≈ $-1.72 Million	-0.201x	+73.90%
2003-12-31	Skr35.88 Million ≈ $3.86 Million	Skr-27.59 Million ≈ $-2.97 Million	-0.769x	+5.68%
2002-12-31	Skr25.52 Million ≈ $2.75 Million	Skr-20.80 Million ≈ $-2.24 Million	-0.815x	--

About Orexo AB

ST:ORX Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$70.45 Million

Skr654.63 Million SEK

Market Cap Rank

#20535 Global

#367 in Sweden

Share Price

Skr18.86

Change (1 day)

-0.32%

52-Week Range

Skr13.80 - Skr41.60

All Time High

Skr85.70